Cargando…
Myostatin in the Pathophysiology of Skeletal Muscle
Myostatin is an endogenous, negative regulator of muscle growth determining both muscle fiber number and size. The myostatin pathway is conserved across diverse species ranging from zebrafish to humans. Experimental models of muscle growth and regeneration have implicated myostatin as an important m...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd.
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2647158/ https://www.ncbi.nlm.nih.gov/pubmed/19412331 http://dx.doi.org/10.2174/138920207783591672 |
_version_ | 1782164907076091904 |
---|---|
author | Carnac, Gilles Vernus, Barbara Bonnieu, Anne |
author_facet | Carnac, Gilles Vernus, Barbara Bonnieu, Anne |
author_sort | Carnac, Gilles |
collection | PubMed |
description | Myostatin is an endogenous, negative regulator of muscle growth determining both muscle fiber number and size. The myostatin pathway is conserved across diverse species ranging from zebrafish to humans. Experimental models of muscle growth and regeneration have implicated myostatin as an important mediator of catabolic pathways in muscle cells. Inhibition of this pathway has emerged as a promising therapy for muscle wasting. Here we discuss the recent developments and the controversies in myostatin research, focusing on the molecular and cellular mechanisms underlying the actions of myostatin on skeletal muscle and the potential therapeutic role of myostatin on muscle-related disorders. |
format | Text |
id | pubmed-2647158 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Bentham Science Publishers Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-26471582009-04-30 Myostatin in the Pathophysiology of Skeletal Muscle Carnac, Gilles Vernus, Barbara Bonnieu, Anne Curr Genomics Article Myostatin is an endogenous, negative regulator of muscle growth determining both muscle fiber number and size. The myostatin pathway is conserved across diverse species ranging from zebrafish to humans. Experimental models of muscle growth and regeneration have implicated myostatin as an important mediator of catabolic pathways in muscle cells. Inhibition of this pathway has emerged as a promising therapy for muscle wasting. Here we discuss the recent developments and the controversies in myostatin research, focusing on the molecular and cellular mechanisms underlying the actions of myostatin on skeletal muscle and the potential therapeutic role of myostatin on muscle-related disorders. Bentham Science Publishers Ltd. 2007-11 /pmc/articles/PMC2647158/ /pubmed/19412331 http://dx.doi.org/10.2174/138920207783591672 Text en ©2007 Bentham Science Publishers Ltd. http://creativecommons.org/licenses/by/2.5/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.5/) which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Article Carnac, Gilles Vernus, Barbara Bonnieu, Anne Myostatin in the Pathophysiology of Skeletal Muscle |
title | Myostatin in the Pathophysiology of Skeletal Muscle |
title_full | Myostatin in the Pathophysiology of Skeletal Muscle |
title_fullStr | Myostatin in the Pathophysiology of Skeletal Muscle |
title_full_unstemmed | Myostatin in the Pathophysiology of Skeletal Muscle |
title_short | Myostatin in the Pathophysiology of Skeletal Muscle |
title_sort | myostatin in the pathophysiology of skeletal muscle |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2647158/ https://www.ncbi.nlm.nih.gov/pubmed/19412331 http://dx.doi.org/10.2174/138920207783591672 |
work_keys_str_mv | AT carnacgilles myostatininthepathophysiologyofskeletalmuscle AT vernusbarbara myostatininthepathophysiologyofskeletalmuscle AT bonnieuanne myostatininthepathophysiologyofskeletalmuscle |